Home > Search: Palgic-D Extended-Release Tablets

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Palgic-D Extended-Release Tablets All Topic Areas 1 - 10 of 437  more >> Carbinoxamine and Pseudoephedrine Extended-Release Tablets Coldec D Extended-Release Tablets Palgic-D Extended-Release Tablets Rondec-TR Tablets Carbinoxamine and Pseudoephedrine Tablets Coldec D Tablets Palgic D Tablets Rondec Tablets Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules Dilatrate-SR Articles 1 - 1 of 1 Statement on Generic Oxycodone Hydrochloride Extended Release Tablets The Food and Drug Administration today released the following statement on its approval of generic oxycodone hydrochloride extended-release tablets: Oxycodone hydrochloride extended-release products, such as OxyContin and its generic versions, are important options for the management of moderate-to-severe chronic pain, such as that associated with cancer and various other illnesses. FDA's approval of two generic oxycodone hydrochloride products should make this safe and effective medicine... U.S. Food and Drug Administration News 1 - 5 of 1188  more >> FDA Approves First Generic Bupropion Hydrochloride Extended-Release Tablets MedicalNewsToday - Thu, 28 Dec 2006 08:00 EST Actavis Launches Alprazolam ER Tablets In The U.S. MedicalNewsToday - Thu, 15 Feb 2007 08:00 EST Slow-release Morphine Reduces Level Of Intractable Cough ScienceDaily - Wed, 28 Feb 2007 04:00 EST Arkansas House Panel Endorses Bill That Would Require Inmates To Receive HIV Test Before Release MedicalNewsToday - Fri, 02 Mar 2007 12:00 EST Bacteria Research Offers Hope For New Vaccine Against Meningococci MedicalNewsToday - Fri, 23 Feb 2007 08:00 EST Clinical Trials 1 - 5 of 370  more >> Study Evaluating LAMICTAL Extended-release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures ClinicalTrials.gov Identifier: NCT00113165 - Active, not recruiting Epilepsy Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting Epilepsy, Partial Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting Pain Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease ClinicalTrials.gov Identifier: NCT00348309 - Recruiting Alzheimer Disease Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease ClinicalTrials.gov Identifier: NCT00348140 - Recruiting Alzheimer's Disease

GoldBambooTM Your Integrative Health and Wellness Resource November 24, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.